Rheumatoid Arthritis: Current Studies, Therapeutic Options and Mechanisms of Action

This activity is intended to advance participant knowledge, competence and performance and to encourage changes in practice that address gaps in clinical practice relating to management of patients who experience nonresponse to first line therapy for rheumatoid arthritis.

Medium: Online + Mobile Video

Commercial Support Statetements: Supported by educational grants from AbbVie and Genentech and by an educational donation provided by Amgen.

Joint Provider: Curatio CME Institute LLC

Target Audience

This activity is intended for the education of rheumatologists, rheumatology nurse practitioners, rheumatology physician assistants and other health care providers involved in the management and treatment of patients who have been diagnosed with RA.

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  • Describe therapeutic mechanisms of intervention for newer agents for rheumatoid arthritis;
  • Analyze recent safety and efficacy data for newer agents used to treat rheumatoid arthritis;
  • Formulate strategies to manage treatment of patients with rheumatoid arthritis who do not respond adequately to their current therapeutic regimen.
Additional information
ACGME/ABMS Core Competencies: 
Medical Knowledge
Summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Activity opens: 
03/17/2015
Activity expires: 
03/17/2016

Gregg J. Silverman, MD
Professor of Medicine & Pathology
NYU School of Medicine
New York, NY

Joel Kremer, MD
Pfaff Family Professor of Medicine
Albany Medical College
Director of Research
The Center for Rheumatology
Albany, NY

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Chicago Pritzker School of Medicine and Curatio CME Institute LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
 
Credit Designation Statement
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

Please login or create an account to proceed.